| Murli Manohar, MD PHD | |
|
4942 Higbee Ave Nw, Suite E, Canton, OH 44718 | |
| (330) 492-4321 | |
| (330) 492-9159 |
| Full Name | Murli Manohar |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 48 Years |
| Location | 4942 Higbee Ave Nw, Canton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518043728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 35041892 (Ohio) | Primary |
| 207R00000X | Internal Medicine | 35041892 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aultman Hospital | Canton, OH | Hospital |
| Mailing Address | Practice Location Address |
|---|---|
| Murli Manohar, MD PHD 4942 Higbee Ave Nw, Suite E, Canton, OH 44718 Ph: (330) 492-4321 | Murli Manohar, MD PHD 4942 Higbee Ave Nw, Suite E, Canton, OH 44718 Ph: (330) 492-4321 |
News Archive
The British Association of Aesthetic Plastic Surgeons (BAAPS) says they are "increasingly concerned" with regard to some of the standards in the advertising of popular cosmetic procedures.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has been included on the list of preliminary additions to the Russell 3000® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010. All Russell indexes are subindexes of the Global Index.
Tomorrow's leaders in science and medicine graduate Friday from the biomedical summer internship program at the Translational Genomics Research Institute.
Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.
Patients with advanced kidney cancer live for nearly twice as long without their disease progressing if they are treated with cabozantinib, a drug that inhibits the action of tyrosine kinases - enzymes that function as an "on" or "off" switch in many cellular processes, including cancer.
› Verified 1 days ago
Nishad Avinash Barve, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1000 | |
Todd L Johnson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4466 Fulton Dr Nw, Canton, OH 44718 Phone: 330-489-1386 Fax: 330-489-1258 | |
John C Tsai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4466 Fulton Dr Nw, Canton, OH 44718 Phone: 330-489-1386 Fax: 330-489-1258 | |
David Andrew Beard, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 6th St Sw, Canton, OH 44710 Phone: 330-363-2180 | |
Yara Khouri, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Sixth St Sw, Canton, OH 44710 Phone: 330-363-6235 | |
Dr. Mitchell Haut, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1455 Harrison Ave Nw, Ste 105, Canton, OH 44708 Phone: 330-453-9993 Fax: 330-453-9996 | |
Ramana Podugu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 6th St Sw, Suite A2-710, Canton, OH 44710 Phone: 330-454-8076 Fax: 330-454-3927 |